Is increasing pretreatment HIV drug resistance a real menace or minor detail?

Podobne zapisy

• Pan-resistant HIV-1: what's next?
  od: Hamers, RL, i wsp.
  Wydane: (2020)
• Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens
  od: Inzaule, SC, i wsp.
  Wydane: (2019)
• Does tenofovir-containing first-line antiretroviral therapy mitigate the impact of pretreatment non-nucleoside reverse transcriptase inhibitor drug resistance?
  od: Inzaule, SC, i wsp.
  Wydane: (2018)
• When prevention of mother-to-child HIV transmission fails: preventing pretreatment drug resistance in African children
  od: Inzaule, S, i wsp.
  Wydane: (2018)
• Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries.
  od: Neil Parkin, i wsp.
  Wydane: (2023-01-01)